Acadia Pharmaceuticals Names Carl Segerstrom as Chief People Officer Effective July 2026
ACAD•Acadia Pharmaceuticals has appointed Carl Segerstrom as Chief People Officer effective July 6, 2026, adding a seasoned executive to its leadership team. Segerstrom will oversee talent strategy and organizational development to support the company's expansion in neurology drug development.
1. Appointment of Chief People Officer
On July 6, 2026, Acadia Pharmaceuticals announced the appointment of Carl Segerstrom as Chief People Officer. Segerstrom brings extensive human resources leadership experience to the company’s executive team.
2. Role Responsibilities and Impact
As Chief People Officer, Segerstrom will oversee talent acquisition, employee engagement and organizational development functions. His leadership is expected to bolster Acadia’s capacity to scale its neurology drug development pipeline and enhance corporate culture.
